Cerulean cataract is a rare form of congenital cataract that is caused by a mutation in the CRYBB2 gene. It is characterized by the presence of blue-gray opacities in the lens of the eye. It is usually diagnosed in infancy or early childhood and can lead to vision loss if left untreated. Treatment typically involves surgical removal of the cataract.

The most common symptom of cerulean cataract is a bluish-gray tint to the vision. Other symptoms may include decreased vision, glare, halos around lights, double vision, and difficulty with night vision.

The most common cause of cerulean cataract is a genetic mutation that affects the proteins in the lens of the eye. Other causes include long-term exposure to ultraviolet light, certain medications, and certain medical conditions such as diabetes.

The primary treatment for cerulean cataract is surgery. During the procedure, the cloudy lens is removed and replaced with an artificial intraocular lens (IOL). This procedure is known as cataract surgery. In some cases, a laser may be used to break up the cataract before it is removed. In addition to surgery, other treatments may include medications, such as topical steroids, to reduce inflammation and swelling.

1. Age: Cerulean cataracts are most commonly seen in people over the age of 40.

2. Genetics: Certain genetic mutations have been linked to an increased risk of developing Cerulean cataracts.

3. Diabetes: People with diabetes are more likely to develop Cerulean cataracts.

4. Prolonged exposure to ultraviolet (UV) light: Prolonged exposure to UV light can increase the risk of developing Cerulean cataracts.

5. Certain medications: Certain medications, such as corticosteroids, can increase the risk of developing Cerulean cataracts.

6. Previous eye surgery: People who have had previous eye surgery are more likely to develop Cerulean cataracts.

At this time, there is no cure for cerulean cataract. However, there are medications that can be used to help manage the symptoms. These medications include topical steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and cycloplegic agents. Additionally, surgery may be recommended in some cases.